In a two-week period this July, Commercial Observer reported on three Midtown office towers hitting the market, a domino-like series of headlines that signaled a decisive shift in seller behavior. First came BXP's ground lease at 7 Times Square, asking north of $700 million for its slice of the 1.2 million-square-foot tower. Just three days later, Empire State Realty Trust's 1359 Broadway was looking for a buyer at roughly $225 million, while Property & Building Corporation's 10 Bryant Park returned to the market for a second try after an $855 million deal fell through in 2022, now seeking more than $800 million. The wave matters because it tests whether the recovery in New York office investment sales can absorb a sudden increase in supply without pressuring pricing.
The mechanics of the listings reveal a market concentrated in prime Midtown and Midtown South corridors, with tenant occupancies at 90 percent and above. August brought Tishman Speyer's 6 Grand Central, a 770,386-square-foot trophy tower seeking roughly $450 million, and China Life Insurance Group marketing its minority stake in RXR's Class A tower at 1285 Sixth Avenue at a price that would value the building at $1.4 billion. On the same day that stake was reported, sources told CO that ESRT's 1359 Broadway had found its buyer in Thor Equities, which agreed to pay $218 million for the 22-story office tower. A few days earlier, the estate of L.H. Charney sold Midtown's 1441 Broadway for $238 million to a partnership of 60 Guilders and Sentry Realty.
The evidence behind this activity comes from a single Commercial Observer report, which draws on brokerage and research commentary. Gary Phillips, managing director at Eastdil Secured Savills and a member of BXP's 7 Times Square broker team, said on-the-market office towers reported thus far are "only a portion of what's out there," and that more are likely to be announced in the coming weeks and months. He traced the ramp-up back to the fourth quarter of 2024, when his team closed the $255 million sale of Columbia Property Trust's 799 Broadway, a 177,000-square-foot office property, to Savanna. Phillips described that deal as "the first aha moment, a Class A trophy-style deal, where it exceeded our expectations," adding that the bid sheet "would have been as if it was 10 years ago."
The sector implications are substantial. This year's activity followed a promising 2025, in which office investments grew 30 percent to exceed $11 billion, according to a JLL analysis. Manhattan office sales in the second quarter of this year totaled $2.3 billion, according to Cushman & Wakefield, rising 42 percent over the same period in 2025 and on par with the five-year quarterly average. Institutional investors and real estate investment trusts are leading the way in acquiring high-quality assets. Phillips said the gap between leasing performance and investment pricing is unusually large right now, with leasing fundamentals leading capital markets "by such a wide margin" that investors do not have to bet on future improvement. He noted that some institutional groups with the most conviction in office are the same groups that have had to look for their own space, underscoring how tight top-shelf availability has become.
The report leaves important limitations and unknowns. The dossier does not include final sale prices for most of the newly listed towers, nor does it provide data on how many listings may fail to trade. The evidence level is a single full-text source, so the analysis cannot independently corroborate the brokerage commentary or the research figures cited. What to watch is whether the quick succession of towers hitting the market creates pricing pressure, and whether the leasing strength Phillips describes translates into completed transactions at or near asking levels. The source itself notes that more listings are likely to be announced in the coming weeks and months, making the absorption of this pipeline the key test of the recovery's durability.